BMO Capital's Kelly Bania reiterates Market Perform for Target but lowers the price target from $170 to $155. Despite 1Q results meeting expectations, concerns arise over continued gross margin upside, share losses in food and consumables, and competition from Amazon and Walmart.
Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.
On Wednesday, Nvidia Corporation (NASDAQ: NVDA) reported its fiscal first quarter results, surpassing both top and bottom-line estimates as demand for AI chips remains as robust as ever.
Boeing Company (NYSE: BA) shares are down more than 6% on Thursday following CFO Brian West's announcement that the company will burn cash in 2024 rather than generate it.
Upgraded to Outperform with $270 price target by RBC analyst due to expected improvement in operating ratio and EPS growth, making NSC an attractive investment opportunity.